{"lastClose": 10.979999542236328, "len": 615, "date": "2022-12-30", "alpha_1": -0.3052017987422483, "beta_1": 1.6455734061030405, "drawup_1": 1.513959286579007, "natr_1": 12.684649483573349, "sup_1": -0.18366725832693206, "res_1": 0.31481485341729837, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 36.889247405605445, "adx_1": 52.02312865932306, "drawdown_1": -0.7342327077294066, "stratHoldSharpe_1": -0.8107685597859323, "stratHoldAlpha_1": 250.42973661265853, "stratHoldDrawdown_1": -0.6623732160430409, "alpha_3mo": -0.11812481257672836, "beta_3mo": 1.937576240011102, "drawup_3mo": 0.3422263391162379, "natr_3mo": 12.684649483573349, "sup_3mo": -0.05798415360329666, "res_3mo": 0.02519738511408724, "bullPattern_3mo": ["SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 42.3510417776855, "adx_3mo": 47.24638772593297, "drawdown_3mo": -0.3241946844717246, "stratHoldSharpe_3mo": -0.15174220257040777, "stratHoldAlpha_3mo": 250.90597905445065, "stratHoldDrawdown_3mo": -0.29742195308820574, "Sector": "Health Care", "Industry": "Biotechnology: Pharmaceutical Preparations", "Market Cap": 517682635, "Name": "Nurix Therapeutics Inc. Common stock", "IPO Year": 2020.0, "Country": "United States", "alpha%_1": 0.31193132918274025, "beta%_1": 0.8996638467652489, "drawup%_1": 0.9994830144570958, "natr%_1": 0.9993949569516469, "drawdown%_1": 0.054869475344801404, "stratHoldSharpe%_1": 0.22981991224205095, "stratHoldAlpha%_1": 0.0668955508582027, "stratHoldDrawdown%_1": 0.058179429703134, "alpha%_3mo": 0.27565826926153414, "beta%_3mo": 0.9651079478224519, "drawup%_3mo": 0.7363275061017202, "natr%_3mo": 0.9993034489135979, "drawdown%_3mo": 0.0647728686347621, "stratHoldSharpe%_3mo": 0.28692192152277224, "stratHoldAlpha%_3mo": 0.2925722651866655, "stratHoldDrawdown%_3mo": 0.06048402961065634}